Citigroup’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.8K | Sell |
23,924
-21,619
| -47% | -$25.1K | ﹤0.01% | 4268 |
|
|
2025
Q1 | $61.5K | Sell |
45,543
-7,038
| -13% | -$9.5K | ﹤0.01% | 4054 |
|
|
2024
Q4 | $692K | Buy |
52,581
+3,041
| +6% | +$40.1K | ﹤0.01% | 2816 |
|
|
2024
Q3 | $555K | Buy |
49,540
+31,991
| +182% | +$359K | ﹤0.01% | 2928 |
|
|
2024
Q2 | $189K | Sell |
17,549
-195,756
| -92% | -$2.1M | ﹤0.01% | 3185 |
|
|
2024
Q1 | $3.18M | Buy |
213,305
+141,830
| +198% | +$2.11M | ﹤0.01% | 1514 |
|
|
2023
Q4 | $1.29M | Buy |
71,475
+57,949
| +428% | +$1.05M | ﹤0.01% | 1973 |
|
|
2023
Q3 | $235K | Sell |
13,526
-10,758
| -44% | -$187K | ﹤0.01% | 2904 |
|
|
2023
Q2 | $440K | Sell |
24,284
-509
| -2% | -$9.22K | ﹤0.01% | 2816 |
|
|
2023
Q1 | $659K | Sell |
24,793
-702
| -3% | -$18.7K | ﹤0.01% | 2323 |
|
|
2022
Q4 | $493K | Buy |
25,495
+19,843
| +351% | +$384K | ﹤0.01% | 2546 |
|
|
2022
Q3 | $118K | Buy |
5,652
+4,481
| +383% | +$93.6K | ﹤0.01% | 3312 |
|
|
2022
Q2 | $9K | Sell |
1,171
-891
| -43% | -$6.85K | ﹤0.01% | 4664 |
|
|
2022
Q1 | $14K | Sell |
2,062
-5,723
| -74% | -$38.9K | ﹤0.01% | 4599 |
|
|
2021
Q4 | $105K | Buy |
7,785
+2,858
| +58% | +$38.5K | ﹤0.01% | 3947 |
|
|
2021
Q3 | $83K | Buy |
4,927
+708
| +17% | +$11.9K | ﹤0.01% | 3742 |
|
|
2021
Q2 | $123K | Buy |
4,219
+1,143
| +37% | +$33.3K | ﹤0.01% | 3775 |
|
|
2021
Q1 | $121K | Sell |
3,076
-429
| -12% | -$16.9K | ﹤0.01% | 3618 |
|
|
2020
Q4 | $80K | Buy |
3,505
+3,005
| +601% | +$68.6K | ﹤0.01% | 3823 |
|
|
2020
Q3 | $11K | Buy |
+500
| New | +$11K | ﹤0.01% | 4268 |
|